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Peptide-nucleotide antibiotic microcin C (McC) is produced by some Escherichia coli strains. Inside a sensitive cell, McC is pro-
cessed, releasing a nonhydrolyzable analog of aspartyl-adenylate, which inhibits aspartyl-tRNA synthetase. The product ofmccE,
a gene from the plasmid-borneMcC biosynthetic cluster, acetylates processedMcC, converting it into a nontoxic compound.
MccE is homologous to chromosomally encoded acetyltransferases RimI, RimJ, and RimL, which acetylate, correspondingly, the
N termini of ribosomal proteins S18, S5, and L12. Here, we show that E. coli RimL, but not other Rim acetyltransferases, pro-
vides a basal level of resistance toMcC and various toxic nonhydrolyzable aminoacyl adenylates. RimL acts by acetylating pro-
cessedMcC, which along with ribosomal protein L12 should be considered a natural RimL substrate. When overproduced, RimL
also makes cells resistant to albomycin, an antibiotic that upon intracellular processing gives rise to a seryl-thioribosyl pyrimi-
dine that targets seryl-tRNA synthetase. We further show that E. coli YhhY, a protein related to Rim acetyltransferases but with-
out a known function, is also able to detoxify several nonhydrolyzable aminoacyl adenylates but not processedMcC.We propose
that RimL and YhhY protect bacteria from various toxic aminoacyl nucleotides, either exogenous or those generated inside the
cell during normal metabolism.
Peptide-nucleotide antibiotic microcin C (McC) consists of anMRTGNAD heptapeptide with a modified AMP attached to
the carboxyl group of the aspartate through anN-acyl phospho-
ramidate linkage (Fig. 1). The N-terminal methionine is formy-
lated; the phosphate group is decorated with a propylamine
group. The peptide moiety of McC is encoded by a 21-bp-long
mccA gene (1, 2). The remaining genes of the mcc cluster are re-
sponsible for the synthesis of antibiotic (mccB, mccD, and mccE)
and immunity of the producing cell to both endogenous and ex-
ogenous McC (mccC,mccE, andmccF).
Escherichia coli cells actively importMcC through the action of
the YejABEF inner membrane transporter (3). Inside the cell, the
N-terminal formyl group ofMcC is removed by peptide deformy-
lase Pdf, and the peptide part is next degraded by one of the three
cellular aminopeptidases—A, B, or N (4). As a result, processed
McC is generated (Fig. 1). Processed McC is a nonhydrolyzable
analog of aspartyl-adenylate (Fig. 1), an intermediate of a tRNAAsp
aminoacylation reaction catalyzed by aspartyl-tRNA synthetase
(AspRS) (5). Processed McC binds to AspRS and inhibits it, lead-
ing to the cessation of production of Asp-tRNAAsp, a stringent
response, and the cessation of protein synthesis. Processed McC
generated internally within the producing cell is detoxified by the
acetyltransferase activity of the C-terminal domain of the MccE
protein (MccECTD).MccECTD acetylates the primary amino group
of the aminoacyl moiety of processed McC; acetylated processed
McC no longer inhibits AspRS (6). MccECTD also acetylates (and,
therefore, provides resistance to) a wide spectrum of nonhydro-
lyzable synthetic aminoacyl sulfamoyl adenylates (aaSAs, where
“aa” denotes an amino acid in a single-letter code) such as DSA,
shown in Fig. 1.
The MccE acetyltransferase is homologous to bacterial N-ter-
minal acetyltransferases (NATs) of the Rim family. The E. coli
genome encodes three Rim proteins, RimI, RimJ, and RimL,
which acetylate ribosomal proteins S18, S5, and L12, respectively
(7, 8). The physiological functions of these NATs and the signifi-
cance of ribosomal protein acetylation for cell physiology are not
entirely clear. Here, we investigated whether sequence similarity
of MccECTD with Rim family NATs leads to functional similarity
and allows RimNATs to play a role inMcC resistance. Our results
indicate that RimL indeed contributes to the basal level of McC
resistance through the same mechanism as the MccE acetyltrans-
ferase. In contrast, RimI and RimJ do not recognize processed
McC or its analogs and play no role in McC resistance. We also
demonstrate that an additional E. coli NAT, the product of the
yhhY gene, acetylates some nonhydrolyzable aminoacyl adenyl-
ates (but not processed McC) and increases cellular resistance to
these compounds.
MATERIALS AND METHODS
Bacterial strains and reagents. E. coli NovaBlue Singles competent cells
(Novagen) were used for cloning and plasmid propagation. E. coli
BL21(DE3) isolates were used for recombinant protein overproduction.
E. coli K-12 strain BW25113 [lacIp4000 (lacIq) rrnB3 lacZ4787 hsdR541
(araBAD)567 (rhaBAD)568 rhp-1] (9) was used as a parental strain to
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generate rim knockouts. The YhhY open reading frame (ORF) clone from
the ASKA library (10) was used for purification of the YhhY protein. All
restriction enzymes, Vent DNA polymerase, TaqDNApolymerase, DNA,
andproteinmolecularweightmarkerswere purchased fromNewEngland
BioLabs Inc. T4 DNA ligase was from Fermentas. All oligonucleotide
primers were synthesized by Integrated DNA Technologies.
Microcin C and its maturation derivative McC(1120) were purified as
described elsewhere (11). Albomycin was a gift of G. Katrukha (Gause
Institute of Antibiotics, Moscow, Russia). Aminoacyl sulfamoyl adenyl-
ates and synthetic McC analogs were synthesized as described previously
(12).
Cloning and protein expression. The N-acetyltransferase genes—
rimI, rimJ, and rimL—were amplified from E. coli BW25113 genomic
DNA with appropriate primers containing engineered NdeI and EcoRI
restriction sites for subsequent cloning. PCR products were blunt-end
cloned into pT7Blue vector (Novagen), excised with NdeI and EcoRI en-
zymes, and recloned into pET28a expression vector (Novagen). All plas-
mids were confirmed by DNA sequencing.
E. coli BL21(DE3) cells harboring the pET28a-rimI (or -rimJ or -rimL)
plasmids were grown in 1 liter of LB medium, supplemented with 25
g/ml kanamycin, at 37°C until an optical density at 600 nm (OD600) of
1 was reached. Cultures were cooled down to 16°C, expression of plas-
mid-borne rim genes was induced by the addition of 0.2 mM isopropyl
1-thio--D-galactopyranoside, and growth at 16°C was continued for 20
to 24 h. Cells were harvested by centrifugation and stored at80°C before
use. An ASKA library clone overproducing YhhY was grown and induced
according to a protocol published elsewhere (10).
In vivo sensitivity tests. E. coli Bl21(DE3) cells carrying pET28a,
pET28a-rimL, pET28a-rimI, pET28a-rimJ, or pET28a-yhhY plasmids
were grown in 5 ml of LB medium supplemented with kanamycin (50
g/ml) and isopropyl -D-thiogalactopyranoside (0.1 mM) at 30°C over-
night. One hundred microliters of culture was mixed with melted LB top
(0.7 g/liter) agar and poured onto the surface of an LB agar plate supple-
mented with kanamycin (50 g/ml). Drops (5 l) of solutions of the
antibiotics being testedwere deposited on the solidified top agar layer. The
concentration ofMcC,McC(1120), and albomycin was 100M, the con-
centration of synthetic McC analog solutions was 350 M, and the con-
centration of aaSA solutions was 10mM. Plates were incubated for several
hours at 30°C. The sizes of growth inhibition zones around the drops of
antibiotic solutions were monitored and recorded. Each experiment was
repeated at least three times.
Testswith cells lacking rim geneswere performed similarly, except that
the LB medium contained no antibiotics and plates were incubated at
37°C.
Protein purification. To purify RimI or RimL, the frozen cell mass
was thawed and sonicated in a water-ice bath in buffer A containing 20
mMTris-HCl (pH 8.0), 0.5MNaCl, 2mM2--mercaptoethanol, and 0.1
mM phenylmethylsulfonyl fluoride (PMSF). The lysate was clarified by
centrifugation for 30 min at 15,000  g. The supernatant was supple-
mented with 5 mM imidazole and loaded onto a 5-ml Ni HiTrap column
(GE Healthcare) equilibrated with buffer A containing 5 mM imidazole.
Bound protein was step eluted with 20, 50, 100, and 200mM imidazole in
buffer A. Fractions containing pure Rimproteins (as revealed byCoomas-
sie blue staining of SDS gels) were pooled and dialyzed against two ex-
changes of 500 volumes of 40 mM Tris-HCl (pH 8.0), 100 mMNaCl, 0.5
mM EDTA, 0.5 mM 2--mercaptoethanol, and 10% glycerol. Protein
samples were supplemented with glycerol up to 50% stored at20°C. To
purify RimJ protein, a similar protocol was used but with pH 7.0 phos-
phate buffer instead of Tris buffer. The YhhY protein was purified on
HIS-Select nickel affinity gel (Sigma) under denaturing conditions using 8
M urea for protein solubilization and chromatography according to the
manufacturer’s protocol. Fractions with pure protein were pooled and
dialyzed against reconstitution buffer containing 40 mM Tris-HCl (pH
8.0), 200 mM NaCl, 0.5 mM EDTA, 0.5 mM 2--mercaptoethanol fol-
lowed by dialysis against the storage buffer (reconstitution buffer contain-
ing 50% glycerol).
Preparation of E. coli S30 cell extracts. E. coli cells were grown to an
OD600 of0.8 in LB medium. Cells were collected by centrifugation and
washed with 40 mM Tris-HCl (pH 7.6), 10 mM Mg(OAc)2, 50 mM po-
tassium acetate, 0.1 mM EDTA, and 1 mM dithiothreitol (DTT). The cell
pellet was resuspended in an equal volume of the same buffer and dis-
rupted using a French press (pressure, 108 Pa [1,000 bar]). The lysate was
next centrifuged at 30,000  g for 30 min. Then, supernatant was ali-
quoted and either directly used in tRNA aminoacylation reactions or
stored at80°C until further use.
tRNA aminoacylation reaction. Aminoacylation reactions were car-
ried out according to the method described in reference 5 with some
modifications. To 1 l of solution containing an inhibitor being tested, 3
l of E. coli S30 extract was added. Next, 16l of aminoacylationmixture
(30 mM Tris-HCl [pH 8.0], 1 mM DTT, 5 g/liter bulk E. coli tRNA
[Sigma], 3 mM ATP, 30 mM KCl, 8 mM MgCl2, and 40 M desired
labeled amino acid) was added, and reaction mixtures were incubated at
room temperature for 5 min. The reactions were terminated by the addi-
tion of cold 10% trichloroacetic acid (TCA), and precipitated reaction
products were collected on Whatman 3MM paper filters. After thorough
washing with cold 10% TCA, the filters were washed twice with acetone
and dried on a heating plate. Following the addition of scintillation liquid,
the amount of radioactivity was determined in a scintillation counter.
FIG 1 Microcin C and the mechanism of its action. The structures of intact McC, processed McC, aspartyl-adenylate, an intermediate of reaction catalyzed by
AspRS, and aspartyl sulfamoyl adenylate DSA are shown. The propylamine group (shaded) is absent from McC(1120) and its processing product.
Kazakov et al.
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N-Acetyltransferase activity assay. The N-acetyltransferase activity
assay was performed in 20 l of 100 mM Tris-HCl (pH 8.0), 0.1 mM
EDTA, 1mM acetyl coenzyme A (acetyl-CoA), and 0.5 to 1mM substrate
for 10min at 25°C. Reactions were initiated by the addition of 0.07, 0.2, 1,
and 2 M purified recombinant YhhY, RimI, RimL, and RimJ, respec-
tively, and were terminated by the addition of 500 l of 0.05 mM 4,4=-
dithiodipyridine (DTDP) (Aldrich) (13). Enzyme activitywas determined
by measuring the increase in absorbance at 324 nm due to the formation
of 4-thiopyridone in the reaction betweenDTDPand the sulfhydryl group
(SH) of the CoA-SH produced after the acetyl transfer reaction, and spe-
cific activity was calculated as the amount of substrate (mol) converted
into CoA-SH product by 1 mg of enzyme per minute of reaction.
To verify the acetyltransferase activity of recombinant Rim proteins,
synthetic peptides (GenScript) matching the first 10 N-terminal residues
of E. coli ribosomal proteins S18, S5, and L12 were used as the substrates
(acetyl group acceptors) for RimI, RimJ (7), and RimL (8), respectively.
Earlier, such an approach had been applied by the Blanchard group to
analyze bisubstrate inhibition of RimI from Salmonella enterica serovar
Typhimurium (14, 15) and during crystal structure determination of this
enzyme (16). The recombinant enzyme preparations of RimI, RimJ, and
RimL used in this work gave, respectively, the following specific activities
toward chosen cognate synthetic substrates: 0.51, 0.021, and 0.052 mol/
min/mg. No activity to noncognate substrates was detected.
MALDI-TOFMS. Samples formass spectrometric (MS) analysis were
dissolved in acetonitrile. Aliquots (0.5 l) were mixed on a steel target
with 1 l of 2,5-dihydroxybenzoic acid (Aldrich) solution (20 mg/ml in
20%acetonitrile, 0.5% trifluoroacetic acid), and the droplet was left to dry
at room temperature. The mass spectra were recorded on an ABI-MDS
SCIEX 4800 matrix-assisted laser desorption ionization–time of flight
(MALDI-TOF) mass spectrometer. The [MH]	 molecular ions were
measured in reflector and tandem (Lift) mode; the accuracy of mass peak
measurement was 0.1 Da for parent ions and 0.5 Da for daughter ions.
RESULTS
Chromosomally encoded RimL contributes to the basal level of
resistance toMcC, its analogs, and nonhydrolyzable aminoacyl
adenylates. To determine the role of Rim NATs in McC resis-
tance, E. coliK-12-based strains lacking individual rim genes were
constructed. Three strains carrying double rim deletions (rimI
rimJ, rimI rimL, and rimJ rimL) and a triple rimI rimJ
rimL mutant were also constructed. All strains were viable and
grew equally well in rich medium at 37°C (data not shown). Sus-
ceptibilities of mutant strains to (i) McC, (ii) McC(1120), an
1,120-Da McC maturation intermediate lacking the propylamine
modification (11), (iii) two aminoacyl sulfamoyl adenylates
(aaSAs) active against E. coli (aspartyl sulfamoyl adenylate DSA
and leucil sulfamoyl adenylate (LSA) (12), (iv) two synthetic
McC(1120) analogswith anMRTGNApeptide (“X”) correspond-
ing to the first six amino acids of McC heptapeptide coupled to
DSA and LSA (12), and (v) albomycin were next determined.
Drops of solutions containing various compoundswere deposited
on lawns of wild-type or mutant E. coli, and the sizes of growth
inhibition zones were recorded after overnight incubation at
37°C. McC and its analogs were used at 100 and 350 M concen-
trations. AaSAs, which lack the transport peptide, were tested at
the much higher concentration of 10 mM in order to obtain ob-
servable growth inhibition zones. Albomycin was used at a 100
M concentration. Results obtained with the triple mutant strain
are shown in Fig. 2. As can be seen, the mutant cells were more
sensitive to McC, its chemical analogs, or aaSAs than, but were as
sensitive to albomycin as, the wild-type cells. The extent of pro-
tection afforded by chromosomal rim genes varied for different
compounds. Protection was marginal for DSA but very obvious
for McC and McC(1120).
Deletions of rimI and/or rimJ had no effect on sensitivity to any
of the compounds tested (data not shown). Further, the rimI
rimL and rimJ rimL double mutants or the rimI rimJ
rimL triple mutant were no more sensitive than cells lacking
rimL only (data not shown). The result thus suggests that RimL
contributes to the basal level of E. coli resistance to McC, its ana-
logues, and nonhydrolyzable aminoacyl-adenylates but not to al-
bomycin. In contrast, RimL andRimI donot contribute to cellular
resistance to any of the compounds tested.
Cell extracts from wild-type and various rimmutant cells were
prepared, supplemented with McC, and incubated for 15 min.
Elsewhere, we show that a 15-min incubation is sufficient for com-
plete processing ofMcC by cellular peptidases at the conditions of
the assay (4). Indeed, the tRNAAsp aminoacylation reaction was
strongly inhibited when measured after the processing was com-
plete in all extracts (Fig. 3A). However, the tRNAAsp aminoacyla-
tion activity was partially recovered in extracts of wild-type cells
that were incubatedwithMcC for longer periods of time (Fig. 3A).
The recovery of tRNAAsp aminoacylation activity in extracts pre-
pared from rimI, rimJ, or rimI rimJ cells closely followed
that observed in thewild-type cell extract (Fig. 3A). In contrast, no
such recovery was observed in extracts prepared from rimL,
rimI rimL or rimJ rimL double mutants or from rimI
rimJ rimL triple mutant cells: the tRNAAsp aminoacylation ac-
tivity in these extracts appeared to be inhibited irreversibly (Fig.
3A). The results thus indicate that cellular RimL contributes to
the basal level of E. coli resistance to McC by inactivating pro-
cessed McC.
The addition ofMcC(1120) to wild-type cell extract led to par-
FIG 2 Cells lacking rim genes are hypersensitive to McC, its maturation in-
termediates, chemical analogs, and nonhydrolyzable aminoacyl adenylates but
not to albomycin. Five-microliter drops of solutions containing the indicated
compounds were deposited on lawns of wild-type or isogenic mutant rimI
rimJ rimL E. coli cells. After overnight growth at 37°C, the areas of growth
inhibition zones were determined. The bars show mean values obtained in
three independent experiments; the error bars show standard deviations. The
compounds tested included the following: McC (a mature form with amino-
propyl modification [Fig. 1]); McC(1120), an 1,120-Da McC maturation in-
termediate lacking the propylaminemodification; XDSA and XLSA, which are
chemically synthesizedMcC(1120) analogs containing anMRTGNAhexapep-
tide C-terminally fused to aspartyl or leucyl sulfamoyl adenylates, respectively;
aminoacyl sulfamoyl adenylates DSA and LSA carrying aspartyl (Fig. 1) and
leucyl aminoacyl moieties, respectively; and, finally, albomycin.
Acetylation of Processed Microcin C by RimL
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tial inhibition of tRNAAsp aminoacylation at the time of the first
measurement after a 15-min preincubation to allow processing
(Fig. 3B). Upon further incubation, complete recovery from inhi-
bition by McC(1120) was observed. In extracts of triple mutant
cells, McC(1120) fully inhibited tRNAAsp aminoacylation without
subsequent recovery of AspRS activity (Fig. 3B).We conclude that
RimL inactivates processedMcC(1120)more efficiently than pro-
cessed McC. The incomplete initial inhibition by McC(1120) in
wild-type cell extract is therefore likely due to a partial detoxifica-
tion of processed McC(1120) that must be occurring simultane-
ously with the processing of intact McC(1120) during the initial
15-min incubation.
The effect of the DSA addition on aminoacylation of tRNAAsp
in extracts from wild-type or triple mutant cells was also tested.
Since DSA does not require processing, the first measurement of
AspRS activity was performed immediately after the addition of
DSA. As can be seen (Fig. 3B), the AspRS activity in both extracts
was initially inhibited by the addition of DSA but eventually com-
pletely recovered from the inhibition. The absence of requirement
for Rim proteins for recovery from DSA inhibition agrees with in
vivo data showing that the contribution of intracellular Rim pro-
teins to DSA (or XDSA) resistance is only slight (Fig. 2). LSA, a
sulfamoyl adenosine inhibitor of LeuRS, irreversibly inhibited
aminoacylation of tRNALeu in triple mutant cell extracts, but par-
tial recovery from inhibition was observed in wild-type cell ex-
tracts (Fig. 3B), again in agreement with in vivo data, which
showed that cells lacking rimLwere significantly more sensitive to
LSA than wild-type cells (Fig. 2).
Effects of Rim proteins on resistance to McC and related
compounds. Our results suggest either that RimI and RimJ are
not necessary for detoxification of McC and toxic aaSAs or that
intracellular amounts of these proteins are too low to affect McC
and aaSA resistance. PET-based expression plasmids overproduc-
ing E. coli RimI, RimJ, or RimL were constructed. SDS-PAGE
analysis indicated that all three proteins were overproduced at
high (and similar) levels (data not shown). Sensitivity of E. coli
BL21(DE3) cells harboring Rim-overproducing plasmids toMcC,
a collection of bioactive aaSAs (DSA, LSA, KSA, ASA, GSA, FSA,
and PSA), and albomycin was tested. We used all bioactive aaSAs
available to us since we considered that RimI and/or RimJ may be
specific for certain aminoacyl adenylates. Previously, we showed
that cells overproducing MccECTD are resistant to McC, DSA,
LSA, KSA, ASA, GSA, FSA, and albomycin but are sensitive to PSA
(6). This result was reproduced (Table 1). Cells overproducing
RimL were indistinguishable from MccECTD-overproducing cells
(Table 1). In contrast, cells overproducing RimI or RimJ were as
sensitive as cells harboring the PET vector plasmid to every com-
pound tested (Table 1).
The inability of overproduced RimI or RimJ to provide resis-
tance to McC could have been due to poor solubility and/or fold-
ing of recombinant proteins. To rule out this possibility, recom-
binant Rim proteins were purified from cytoplasmic extracts of
appropriate overproducing cells to apparent homogeneity. Con-
trol experiments established that each protein was acetylating its
cognate substrates and was therefore properly folded and active
(see Materials and Methods). The addition of recombinant
MccECTD or RimL—but not RimI or RimJ—to extracts of rimI
rimJ rimL cells inhibited with McC led to almost complete
FIG 3 RimL detoxifies processed McC and LSA in vitro. (A) AspRS-catalyzed
aminoacylation of tRNAAsp in S30 extracts prepared fromwild-type E. coli and
the indicated rim mutants. Extracts were supplied with intact McC and incu-
bated for 15 min to allow processing. Aliquots of extracts were removed, and
tRNAAsp aminoacylation reactions were carried out. The first aliquots were
removed right after the initial 15-min incubation needed for McC processing.
This time point is labeled “0.” The amounts of aminoacylated tRNAAsp (mea-
sured as incorporation of [C14] Asp in TCA-precipitable material) are shown.
Control shows the time course of aminoacylation levels in wild-type S30 cell
extracts without any additions. Data from three independently performed
experiments (mean values and standard deviations) are shown. (B) E. coli S30
extracts prepared from wild-type or a triple rim deletion E. coli strain were
combined with intact McC, McC(1120), DSA, or LSA. Extracts containing
McC or McC(1120) were incubated for 15 min to allow processing before
initiating tests for tRNAAsp aminoacylation (times are indicated as indicated
for panel A); in extracts containing DSA or LSA, measurements of tRNAAsp or
tRNALeu aminoacylation, respectively, were initiated immediately after the
addition of inhibitors. Data from three independently performed experiments
(mean values and standard deviations) are shown.
TABLE 1 Sensitivity of cells overproducing Rim proteins and YhhY to
McC, albomycin, and aaSAsa
Protein McC Albomycin DSA LSA KSA GSA ASA FSA PSA
RimL R R R R R R R R S
RimI S S S S S S S S S
RimJ S S S S S S S S S
YhhY S S S R S S PR PR S
a R, absence of visible growth inhibition zones at the concentration of inhibitor used; S,
clear growth inhibition zones of the same size as observed on control cell lawn formed
by cells carrying a pET28a plasmid vector; PR (partial resistance), presence of turbid
growth inhibition zones whose diameter was at least twice less than that on control
lawn.
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recovery of tRNAAsp aminoacylation after a 3-hour incubation
(Fig. 4A). Simultaneous addition of RimI and RimJ had no effect,
and neither RimI nor RimJ stimulated RimL-mediated recovery
of tRNAAsp aminoacylation (Fig. 4A).
The addition of RimL to albomycin-inhibited extracts led to
recovery of tRNASer aminoacylation (Fig. 4B). No such effect was
observed with RimI or RimJ (data not shown). Since 20-fold-
larger amounts of RimL were required to recover tRNASer amino-
acylation in albomycin-inhibited extracts than to achieve full re-
covery of tRNAAsp aminoacylation in McC-inhibited extracts,
processed albomycin is a much poorer RimL substrate than pro-
cessed McC, in agreement with in vivo data (Fig. 2) and earlier
findings with MccECTD (6).
Purified Rim proteins were combined with acetyl-CoA, a do-
nor of acetyl groups, and the rateofproductionof freeCoAgenerated
during the acetylation reaction was determined in the presence of
processed McC, DSA, ESA, and LSA as described in Materials and
Methods.The results, presented inTable2,demonstrate thatproduc-
tion of CoA from acetyl-CoAwas observed with every aaSA tested in
the presence ofRimL.A similar resultwas obtained in the presence of
MccECTD, as expected (6). In contrast, no CoA production was de-
tected in reactionmixtures that contained RimI or RimJ.
RimL-catalyzed acetylation of aaSAs was confirmed by
MALDI-TOF MS analysis of reaction products (Fig. 5 and data
not shown). In all cases, amass peak corresponding to the reaction
substrate disappeared upon incubation with pure RimL and
acetyl-CoA. Instead, a new peak whosem/z value was increased by
42 atomic units, corresponding to a transfer of an acetyl group,
was observed. Thus, just like MccECTD, RimL can utilize aaSAs as
the substrates for acetylation with little specificity with respect to
the amino acid attached to the nucleotide moiety. RimI and RimJ
are inactive in this reaction.
Identification of an additional E. coli NAT capable of acety-
lating aminoacyl adenylates. MALDI-TOF MS analysis of wild-
type cells extract that recovered from LSA inhibition revealed that
a mass peak corresponding to LSA (m/z 
 460) disappeared. In-
stead, a peak corresponding to acetylated LSA (m/z 
 502) was
observed (Fig. 5). Interestingly, incubation in triple rim mutant
cell extracts also led to the accumulation of detectable amounts of
acetylated form of LSA, though the peak corresponding to unmodi-
fied LSA was also present (Fig. 5). Incubation of wild-type or rim
mutant cell extracts with DSA led to the disappearance of the mass
peak with an m/z of 462, corresponding to DSA (Fig. 5). No peak
corresponding to acetylated or any other modified form of DSAwas
observed.The lackof accumulationof acetylatedDSAwasnot caused
by the inability of RimL to acetylate DSA, since acetylation products
were readily detected upon incubation of either DSA or LSA with
extract prepared fromRimL-overproducing cells (Fig. 5). The results
thus suggest that in wild-type cells DSA is efficiently degraded in a
RimL-independent way, in agreementwith results of in vivo sensitiv-
ity tests (Fig. 2) and in vitro results (Fig. 3B).
Accumulation of a	42 peak in LSA-inhibited extracts lacking
Rim proteins suggested that there exists yet another, non-Rim,
NAT that can acetylate LSA. Bioinformatics analysis of the E. coli
genome reveals several genes coding for putative or experimen-
tally proven acetyltransferases different from the Rim proteins.
The products of two such genes, yhhY and speG, are most closely
related to Rim proteins (Fig. 6A) and were investigated further. A
yhhY deletion strain, a quadruple mutant strain lacking the three
rim genes and the yhhY gene, and a yhhY expression plasmid were
generated. The corresponding speG deletion strains and an ex-
pression plasmid were also made. The sensitivity of yhhY or speG
deletion strains to various inhibitors used in the experiments de-
scribed above was not different from those of control (wild-type
or triple rimmutant) strains (data not shown). SpeG overproduc-
tion hadno effect on the sensitivity of cells toMcCand aaSAs (data
not shown). In contrast, YhhY-overproducing cells became com-
FIG 4 RimL protein is sufficient for McC, McC(1120), DSA, XDSA, LSA, and
albomycin resistance in vitro.Wild-typeE. coli S30 extracts were supplemented
with McC (A) or albomycin (B) and incubated to allow processing. Next, the
indicated purified Rim proteins were added to reaction mixtures (time “0”),
and incubation was continued. At various time points after addition of Rim
proteins, reaction aliquots were withdrawn and tRNAAsp (A) or tRNASer (B)
aminoacylation reactions were carried out. In panel B, a 20-fold-higher con-
centration of RimL (labeled with an asterisk) was used in reaction mixtures
containing albomycin than in those containing SSA, which was used as a con-
trol. Data from three independently performed experiments with each inhib-
itor are shown (with means and standard deviations).
TABLE 2 In vitro substrate specificity of E. coli Rim and YhhY
acetyltransferases
Substrate
Sp acta (mol/mg/min)
RimI RimJ RimL YhhY
DSA 0 0 2.39 0
ESA 0 0 1.54 0
LSA 0 0 2.11 28
ISA ND ND 2.5 17
Albomycin 0 0 0 ND
a Amount of product in the presence of 1 mM acetyl-CoA and 0.5 to 10 mM substrates
(see Materials and Methods); ND, not determined.
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pletely resistant to LSA and were partially resistant to ASA and
FSA but remained as sensitive to McC, DSA, KSA, GSA, and PSA
as control cells harboring an empty vector plasmid (Table 1). The
results thus indicate that YhhY, when overproduced, can indeed
provide resistance to some nonhydrolyzable aminoacyl adenyl-
ates.
S30 extracts from triple rim and quadruple deletion (triple rim
and yhhY) were incubated with LSA, followed by MALDI-TOF
MS analysis. While partial conversion of LSA to a 	42 mass ion
with an m/z of 502 was detected in triple mutant cells, the LSA
peak remained intact in the quadruple mutant cell extract and no
peak with m/z of 502 was detected (Fig. 6B). We therefore con-
FIG 5 Mass spectrometric analysis of LSA and DSA incubated in various cell extracts. LSA and DSA were incubated with a buffer (control) or with S30 extracts
prepared fromwild-type,rim, or RimL-overproducing cells, and reactions were subjected toMALDI-TOFMS analysis. Only relevant portions of mass spectra
are shown. The peaks corresponding to mass ions described in the text are in ovals.
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clude that endogenous YhhY is responsible for acetylation of LSA
in the absence of RimL.
The YhhY protein was purified, and its ability to acetylate several
substrateswas determined. The results, presented inTable 2, indicate
that YhhY was approximately 10 times more active than RimL in
acetylation of LSA and ISA but was unable to utilize DSA and ESA as
acetylation substrates, in agreement with in vivo results.
DISCUSSION
The principal result of this work is the demonstration that
the Escherichia coli RimL protein contributes to microcin C resis-
tance by acetylating the amino group of the processedMcC aspar-
tate moiety. In this respect, RimL appears to be very similar to the
C-terminal domain of MccE acetyltransferase encoded by the
plasmid-borne McC biosynthesis/immunity gene clustermcc (6).
As is the case withMccECTD, the nature of the amino acid appears
to be unimportant for RimL activity, since all aminoacyl sulfamoyl
adenylates containing the primary amine group tested in thiswork
(i.e., Ala, Asp, Gly, Phe, Lys, Glu, Leu, and Ile sulfamoyl adenyl-
ates) are efficiently acetylated. The nature of the bond between the
aminoacyl and nucleotide moiety is also unimportant, since com-
pounds containing either phosphoamide or sulfamoyl are recog-
nizedwell. Processed albomycin, which contains a pyrimidine nu-
cleotide instead of adenosine, is also acetylated by RimL, albeit
FIG 6 YhhY is an acetyltransferase that detoxifies nonhydrolyzable aminoacyl adenylates in vivo and in vitro. (A) A multiple sequence alignment of E. coli Rim
proteins, MccECTD, SpeG, and the YhhY protein. The extent of sequence conservation is indicated by background shading. Catalytic and substrate binding
residues are marked with asterisks. Residues 22, 41, and 54 of RimL correspond to known adenine-binding residues of MccECTD and likely adenine-binding
residues of YhhY: RimLLys22 corresponds toHis21 of YhhY; Trp41 corresponds to Trp453 ofMccE (Trp46 ofMccECTD) andTrp41 of YhhY, andThr54 corresponds
to Phe466 of MccE (Phe59 of MccECTD) (17). Residue Cys134 of RimL forms a disulfide bond with acetyl-CoA; Ser141 and Glu160 act as general acid/base catalysts
of the acetyltransferase reaction. Alignment was built using MUSCLE software, and the figure was prepared using GENEDOC. (B) LSA was incubated with
extracts prepared from indicated cells and subjected to MALDI-MS analysis. Only relevant portions of mass spectra are shown.
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much less efficiently. Like the MccE acetyltransferase, RimL does
not use free amino acids or intact McC as the substrates.
Structural analysis indicates that the promiscuity of MccECTD
with respect to aminoacyl moieties of its substrates is due to tight
binding to substrate nucleotidyl moiety through stacking interac-
tions with two aromatic amino acids of the protein, Trp453 and
Phe466, and the absence of contacts with the aminoacyl moiety of
the substrate (17). The available crystal structure of RimL from
Salmonella (16) reveals a conservation of only one of the -stack-
ing residues, Trp41, which corresponds toMccE Trp453 (MccECTD
Trp46) (Fig. 6A). Though a second aromatic residue correspond-
ing to MccE Phe466 (MccECTD Phe59) is missing, the other face of
the active site of RimL is lined with hydrophobic amino acids such
as Leu24, Met69, and Val81; a histidine side chain (His54) is also
placed in close proximity. In the SalmonellaRimI crystal structure
(18), a duet of similar stacking residues—Trp27 and His32—can
be identified. However, the adenine-binding site in RimI is oc-
cluded by the carboxylate of Glu19 and the amide side chain of
Asn68. Steric occlusion by these residues could contribute to the
observed inability of RimI to acetylate aminoacyl adenylates by
preventing their binding.
In the active site of YhhY predicted by alignment with the
MccECTD structure, His21 and the indole ring of Trp41 are pre-
dicted to stack on either side of the substrate adenine ring analo-
gous to Trp453 and Phe466 of MccECTD. Thus, a purine nucleobase
binding motif created by two parallel planar aromatic amino acid
side chains appears to be a common mechanism for engagement
of aminoacyl adenylates by NATs. The narrower specificity of
YhhY toward its substrates (the obvious preference for com-
pounds with amino acids containing nonpolar side chains) sug-
gests that this protein contains an additional hydrophobic pocket
that accepts this part of the substrate.
Interestingly, our data reveal that though purified RimL can
effectively acetylate and therefore detoxify DSA, another system
efficiently removes DSA from E. coli cell extracts whether RimL is
present or not. This yet-to-be identified system appears to degrade
DSA, which completely disappears from the extracts, and mass
spectrometric analysis fails to reveal peaks that could correspond
to modified DSA. This additional system is not functional against
McC(1120), whose processing product is identical for DSA except
for a phosphoamide bond instead of sulfamoyl.
There are three Rim proteins encoded by the E. coli genome.
RimI was discovered as an enzyme responsible for acetylation of
ribosomal protein S18 (19), and RimJ acetylates ribosomal pro-
tein S5 (20), while RimL acetylates the L12 protein, converting it
to L7 (21). The importance of the Rim proteins and the acetyl
transfer reactions that they catalyze for cell physiology is not clear
at present. In vitro, L7 forms a more stable complex with the L10
protein than does L12 (22). The L7/L12 ratio is higher in cells
grown in poor medium (23), suggesting that RimL activity is ac-
tivated by nutrient deprivation. These conditions also stimulate
McCproduction by cells harboring themcc operon (24). Be that as
it may, none of the Rim proteins or combinations thereof is essen-
tial for viability at 37°C (though temperature sensitivity was noted
for a rimL rimJ deletion mutant [18–20]). In fact, Rim proteins
may have functions that are unrelated to N-acetylase activity. For
example, RimJ plays an important role in the process of assembly
of the 30S ribosomal subunits (25), and this involvement does not
depend on the function of acetyltransferase. The data presented
here indicate that some Rim proteins and other E. coli NATs of
unassigned functions may acetylate aminoacyl nucleotides that
accumulate either during cell metabolism or as a result of antibi-
otic treatment and thus contribute to bacterial cell fitness. More-
over, these proteins can also serve as an important source of anti-
biotic resistance.
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